Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3051% below fair value
$0.74+0.00 (+0.11%)
Close on Nov 18, 2026Market cap $37.00MP/E –Yield –
Rapid Micro Biosystems free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Rapid Micro Biosystems's free cash flow for the twelve months ending Jun 30, 2026 was -$40.39M. For fiscal 2025 it was -$31.91M. The highest annual figure on record is -$31.69M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$31.91M | – |
| FY2024 | Dec 31, 2024 | -$45.52M | – |
| FY2023 | Dec 31, 2023 | -$46.93M | – |
| FY2022 | Dec 31, 2022 | -$65.29M | – |
| FY2021 | Dec 31, 2021 | -$58.18M | – |
| FY2020 | Dec 31, 2020 | -$31.69M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$12.48M | – |
| Q1 FY2026 | Mar 31, 2026 | -$15.45M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.34M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.07M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.38M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.01M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.82M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.58M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.11M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.92M | – |
| Q3 FY2023 | Sep 30, 2023 | -$10.16M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.41M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.45M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.47M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.69M | – |
| Q2 FY2022 | Jun 30, 2022 | -$16.98M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.15M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.85M | – |
| Q3 FY2021 | Sep 30, 2021 | -$19.77M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.05M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.51M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.30M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.99M | – |
See a number that looks wrong?